Suppr超能文献

中性粒细胞与2019冠状病毒病:迄今为止的进展

Neutrophils and COVID-19: The road so far.

作者信息

Cavalcante-Silva Luiz Henrique Agra, Carvalho Deyse Cristina Madruga, Lima Éssia de Almeida, Galvão José G F M, da Silva Juliane S de França, Sales-Neto José Marreiro de, Rodrigues-Mascarenhas Sandra

机构信息

Laboratório de Imunobiotecnologia, Centro de Biotecnologia, Universidade Federal da Paraíba (UFPB), João Pessoa, Brazil.

Laboratório de Imunobiotecnologia, Centro de Biotecnologia, Universidade Federal da Paraíba (UFPB), João Pessoa, Brazil.

出版信息

Int Immunopharmacol. 2021 Jan;90:107233. doi: 10.1016/j.intimp.2020.107233. Epub 2020 Nov 30.

Abstract

The SARS-Cov2 infection triggers a multisystem inflammatory disorder, knowing as COVID-19, a pandemic disease. This disease is characterized by acute respiratory distress syndrome, cytokine-driven hyperinflammation, and leukocytes count changes. The innate immune response has been linked to COVID-19 immunopathogenesis (e.g., dysfunctional IFN response and myeloid inflammation). In this regard, neutrophils have been highlighted as essential effector cells in the development of COVID-19. This review summarized the significant finds about neutrophils and its effector mechanisms (e.g., neutrophils enzymes and cytokines, neutrophil extracellular traps) in COVID-19 so far.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引发了一种多系统炎症性疾病,即2019冠状病毒病(COVID-19),这是一种大流行性疾病。该疾病的特征是急性呼吸窘迫综合征、细胞因子驱动的过度炎症以及白细胞计数变化。固有免疫反应与COVID-19的免疫发病机制有关(例如,干扰素反应功能失调和髓系炎症)。在这方面,中性粒细胞已被视为COVID-19发展过程中的关键效应细胞。本综述总结了迄今为止关于COVID-19中中性粒细胞及其效应机制(例如,中性粒细胞酶和细胞因子、中性粒细胞胞外陷阱)的重要发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9f/7703515/974a6d1b929d/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验